Pathogenesis of Staphylococcus in the rabbit anterior chamber

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 4, 2005, Pages 1371-1378

  Girgis, Dalia O ^a   Reed, Julian M ^a   Monds, Kathryn S ^a   Dajcs, Joseph J ^a,c   Marquart, Mary E ^a   Thibodeaux, Brett A ^a   O'Callaghan, Richard J ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LSU EYE CENTER   (United States)

^c ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE; PHOSPHOLIPASE A2; STAPHYLOCOCCUS ALPHA TOXIN; PEROXIDASE; PHOSPHOLIPASE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; ENDOPHTHALMITIS; ENZYME ACTIVITY; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STATISTICAL ANALYSIS; SUPERNATANT; ANIMAL; BACTERIAL COUNT; BACTERIAL EYE INFECTION; ENZYMOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTERIOR CHAMBER; AQUEOUS HUMOR; COLONY COUNT, MICROBIAL; EYE INFECTIONS, BACTERIAL; PEROXIDASE; PHOSPHOLIPASES A; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 18244396959     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0888     Document Type: Article

References (47)

1. Aaberg TM, Flynn HW, Schiffman J, Newton J. Nosocomial acute-onset post-operative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology. 1998;105:1004-1010.
2. Kattan HM, Flynn HW, Pflugfelder SC, Robertson C, Forster RK. Nosocomial endophthalmitis survey: current incidence of infection after intraocular surgery. Ophthalmology. 1991;98:227-238.
3. Mao LK, Flynn HW, Miller D, Pflugfelder SC. Endophthalmitis caused by Staphylococcus aureus. Am J Ophthalmol. 1993;116: 584-589.
4. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996;122:1-17.
5. Callegan MC, Engelbert M, Parke DW, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics, and bacteriumhost interactions. Clin Microbiol Rev. 2002;15:111-124.
6. Javitt JC, Street DA, Tielsch JM, et al. National outcomes of cataract extraction: retinal detachment and endophthalmitis after outpatient cataract surgery. Ophthalmology. 1994;101:100-106.
7. Bohigian GM, Olk RJ. Factors associated with a poor visual result in endophthalmitis. Am J Ophthalmol. 1986;101:332-341.
8. Hanscom TA. Postoperative endophthalmitis. Clin Infect Dis. 2004;38:542-546.
9. Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991;98:639-650.
10. Sherwood DR, Rich WJ, Jacob JS, Hart RJ, Fairchild YL. Bacterial contamination of intraocular and extraocular fluids during extracapsular cataract extraction. Eye. 1989;3:308-312.
11. Dickey JB, Thompson KD, Jay WM. Anterior chamber aspirate cultures after uncomplicated cataract surgery. Am J Ophthalmol. 1991;112:278-282.
12. Mistlberger A, Ruckhofer J, Raithel E, et al. Anterior chamber contamination during cataract surgery with intraocular lens implantation. J Cataract Refract Surg. 1997;23:1064-1069.
13. Leong JK, Shah R, McCluskey PJ, Benn RA, Taylor RF. Bacterial contamination of the anterior chamber during phacoemulsification cataract surgery. J Cataract Refract Surg. 2002;28:826-833.
14. 2 in rabbit tears: a host defense against Staphylococcus aureus. Invest Ophthalmol Vis Sci. 2001; 42:2347-2354.
15. 2 activity in normal and Staphylococcus-aureus infected rabbit eyes. Invest Ophthalmol Vis Sci. 2003;44:197-202.
16. Qu XD, Lehrer RI. Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect Immun. 1998;66:2791-2797.
17. 2: Basic and Clinical Aspects of Inflammatory Diseases. Basel: Karger; 1997;31-37.
18. 2: Basic and Clinical Aspects of Inflammatory Diseases. Basel: Karger; 1997;49-55.
19. Saari KM, Saaren-Seppala H, Guillen-Monterrubio O, Hartikainen J, Nevalainen TJ. Phospholipase A2 content of aqueous humour in cataract patients. Acta Ophthalmol Scand. 1995;73:145-147.
20. Diamond JP, Moule K, Leeming JP, Tavare J, Easty DL. Purification of an antimicrobial peptide from rabbit aqueous humour. Curr Eye Res. 1998;17:783-787.
21. Song CH, Choi JS, Kim DK, Kim JC. Enhanced secretory group II PLA2 activity in the tears of chronic blepharitis patients. Invest Ophthalmol Vis Sci. 1999;40:2744-2748.
22. Aho HJ, Saari KM, Kallajoki M, Nevalainen TJ. Synthesis of group II phospholipase A2 and lysozyme in lacrimal glands. Invest Ophthalmol Vis Sci. 1996;37:1826-1832.
23. Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. A new topical model of Staphylococcus corneal infection in the mouse. Invest Ophthalmol Vis Sci. 2003;44:1591-1597.
24. Hume EBH, Dajcs JJ, Moreau JM, Sloop GD, Willcox MD, O'Callaghan RJ. Staphylococcus corneal virulence in a new topical model of infection. Invest Ophthalmol Vis Sci. 2001;42:2904-2908.
25. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun. 1994;62:2478-2482.
26. O'Callaghan RJ, Engel LS, Hill JM. The rabbit intrastromal infection model of bacterial keratitis. In: Zak O, Sande M, eds. Handbook of Animal Models of Infection. London: Academic Press; 1999;367-374.
27. O'Callaghan RJ, Callegan MC, Moreau JM, et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65:1571-1578.
28. Ohara-Nemoto Y, Ikeda Y, Kobayashi M, Sasaki M, Tajika S, Kimura S. Characterization and molecular cloning of a glutamyl endopeptidase from Staphylococcus epidermidis. Microb Pathog. 2002;33: 33-41.
29. Kadry AA, Tawfik AF, Abu El-Asrar AA, Shibl AM. Elucidation of antibiotic effectiveness against Staphylococcus epidermidis during intraocular lens implantation. Int J Antimicrob Agents. 2001;18: 55-59.
30. Schmidt H, Schloricke E, Fislage R, Schulze HA, Guthoff R. Effect of surface modifications of intraocular lenses on the adherence of Staphylococcus epidermidis. Zentralbl Bakteriol. 1998;287:135-145.
31. Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. Pseudomonas aeruginosa in leukopenic rabbits. Curr Eye Res. 1993;12:46l-467.
32. Hobden JA, Engel LS, Hill JM, Callegan MC, O'Callaghan RJ. Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1993;12:469-473.
33. Moreau JM, Sloop GD, Engel LS, Hill JM, O'Callaghan RJ. Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas. Curr Eye Res. 1997;16:1221-1228.
34. Dajcs JJ, Austin MS, Sloop GD, et al. Corneal pathogenesis of Staphylococcus aureus strain Newman. Invest Ophthalmol Vis Sci. 2002;43:1109-1115.
35. Rowsey JJ, Newsom DL, Sexton DJ, Harms WK. Endophthalmitis: current approaches. Ophthalmology. 1982;89:1055-1066.
36. Driebe WT Jr, Mandelbaum S, Forster RK, Schwartz LK, Culbertson WW. Pseudophakic endophthalmitis: diagnosis and management. Ophthalmology. 1986;93:442-448.
37. Olsen JC, Flynn HW, Forster RK, Culbertson WW. Results in the treatment of postoperative endophthalmitis. Ophthalmology. 1983;90:692-699.
38. Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endophthalmitis; review of 36 cases. Ophthalmology. 1982;89: 921-929.
39. Affeldt JC, Flynn HW, Forster RK, Mandelbaum S, Clarkson JG, Jarus GD. Microbial endophthalmitis resulting from ocular trauma. Ophthalmology. 1987;94:407-413.
40. Ormerod LD, Ho DD, Becker LE, et al. Endophthalmitis caused by coagulase-negative staphylococci. 1. Disease spectrum and outcome. Ophthalmology. 1993;100:715-723.
41. Ormerod LD, Becker LE, Cruise RJ, et al. Endophthalmitis caused by coagulase-negative staphylococci. 2. Factors influencing presentation after cataract surgery. Ophthalmology. 1993;100:724-729.
42. Booth MC, Atkuri RV, Nanda SK, Iandola JJ, Gilmore MS. Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis. Invest Ophthalmol Vis Sci. 1995;36:1828-1836.
43. Giese MJ, Mondino BJ. Experimental staphylococcal endophthalmitis. Ophthalmologica. 2001;215:321-336.
44. Silliman CC, Moore EE, Zallen G, et al. Presence of the M-type sPLA2 receptor on neutrophils and its role in elastase release and adhesion. Am J Physiol. 2002;283:C1102-C1113.
45. Nevalainen TJ. Serum phospholipases A2 in inflammatory diseases. Clin Chem. 1993;39:2453-2459.
46. Bazan NG, Allan G. Signal transduction and gene expression in the eye: a contemporary view of the proinflammatory, anti-inflammatory, and modulatory roles of prostaglandins and other bioactive lipids. Surv Ophthalmol. 1997;41:23-34.
47. Pruzanski W, Wadas P. Phospholipase A2-a mediator between proximal and distal effectors of inflammation. Immunol Today. 1991;12:143-146.